Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transcription coregulator activity	TCF4 EWSR1 TAF15 ARID1B FUS TCF20 ARID1A DDX5	3.22e-05	562	45	8	GO:0003712
GeneOntologyMolecularFunction	mRNA 3'-UTR binding	SECISBP2 TAF15 FUS ILF3 DDX5	3.78e-04	276	45	5	GO:0003730
GeneOntologyMolecularFunction	histone H3K36 methyltransferase activity	SETD2 NSD3	3.81e-04	13	45	2	GO:0046975
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TCF4 EWSR1 TAF15 ARID1B FUS TCF20 KLHDC10 ARID1A DDX5	9.71e-04	1160	45	9	GO:0030674
GeneOntologyMolecularFunction	chromatin binding	TCF4 ARID1B CHD7 FUS ARID1A SCML1 DDX5	1.23e-03	739	45	7	GO:0003682
GeneOntologyBiologicalProcess	negative regulation of mRNA metabolic process	SECISBP2 TAF15 FUS RBM10 BAG4	6.28e-06	115	47	5	GO:1903312
GeneOntologyBiologicalProcess	forebrain development	COL3A1 SECISBP2 ROBO1 SETD2 CHD7 DLX5 NF1 ARID1A	1.32e-05	489	47	8	GO:0030900
GeneOntologyBiologicalProcess	regulation of DNA repair	SETD2 ARID1B EYA4 FUS TEX15 ARID1A	1.46e-05	234	47	6	GO:0006282
GeneOntologyBiologicalProcess	regulation of double-strand break repair	SETD2 ARID1B FUS TEX15 ARID1A	2.00e-05	146	47	5	GO:2000779
GeneOntologyBiologicalProcess	negative regulation of mRNA catabolic process	SECISBP2 TAF15 FUS RBM10	4.59e-05	87	47	4	GO:1902373
GeneOntologyBiologicalProcess	regulation of cellular response to stress	SETD2 ARID1B EYA4 FUS TEX15 KLHDC10 ARID1A DDX5	5.52e-05	598	47	8	GO:0080135
GeneOntologyBiologicalProcess	regulation of mRNA metabolic process	RBM5 SECISBP2 TAF15 FUS RBM10 DDX5 BAG4	6.02e-05	443	47	7	GO:1903311
GeneOntologyBiologicalProcess	negative regulation of RNA catabolic process	SECISBP2 TAF15 FUS RBM10	8.22e-05	101	47	4	GO:1902369
GeneOntologyBiologicalProcess	telencephalon development	COL3A1 SECISBP2 ROBO1 CHD7 DLX5 NF1	1.02e-04	332	47	6	GO:0021537
GeneOntologyBiologicalProcess	sensory organ morphogenesis	TSHZ1 CHD7 DLX5 EYA4 NF1 ARID1A	1.22e-04	343	47	6	GO:0090596
GeneOntologyBiologicalProcess	embryonic organ morphogenesis	SETD2 TSHZ1 CHD7 DLX5 EYA4 ARID1A	1.39e-04	351	47	6	GO:0048562
GeneOntologyBiologicalProcess	artery development	COL3A1 ROBO1 CHD7 NF1	2.38e-04	133	47	4	GO:0060840
GeneOntologyBiologicalProcess	olfactory bulb development	ROBO1 CHD7 DLX5	2.40e-04	53	47	3	GO:0021772
GeneOntologyBiologicalProcess	olfactory lobe development	ROBO1 CHD7 DLX5	2.82e-04	56	47	3	GO:0021988
GeneOntologyBiologicalProcess	positive regulation of DNA repair	ARID1B EYA4 FUS ARID1A	3.13e-04	143	47	4	GO:0045739
GeneOntologyBiologicalProcess	regulation of ribonucleoprotein complex localization	SETD2 RBM10	3.90e-04	13	47	2	GO:2000197
GeneOntologyBiologicalProcess	ear morphogenesis	TSHZ1 CHD7 DLX5 EYA4	4.15e-04	154	47	4	GO:0042471
GeneOntologyBiologicalProcess	ribonucleoprotein complex localization	SETD2 RBM10	4.54e-04	14	47	2	GO:0071166
GeneOntologyBiologicalProcess	animal organ morphogenesis	COL3A1 ROBO1 SETD2 TSHZ1 CHD7 DLX5 EYA4 NF1 ARID1A IRX2	4.79e-04	1269	47	10	GO:0009887
GeneOntologyBiologicalProcess	cellular response to growth factor stimulus	COL3A1 ROBO1 TCF4 DLX5 PTPRK PCSK6 DDX5 BAG4	6.07e-04	850	47	8	GO:0071363
GeneOntologyCellularComponent	bBAF complex	ARID1B ARID1A	2.20e-04	10	47	2	GO:0140092
GeneOntologyCellularComponent	npBAF complex	ARID1B ARID1A	4.43e-04	14	47	2	GO:0071564
GeneOntologyCellularComponent	brahma complex	ARID1B ARID1A	4.43e-04	14	47	2	GO:0035060
GeneOntologyCellularComponent	transport vesicle membrane	SEC16B UNC13C HLA-DQA1 SYNPR SYNGR2	4.95e-04	293	47	5	GO:0030658
GeneOntologyCellularComponent	nBAF complex	ARID1B ARID1A	5.82e-04	16	47	2	GO:0071565
GeneOntologyCellularComponent	presynaptic active zone cytoplasmic component	UNC13C PCLO	1.21e-03	23	47	2	GO:0098831
GeneOntologyCellularComponent	neuromuscular junction	UNC13C PCLO SYNGR2	2.05e-03	112	47	3	GO:0031594
GeneOntologyCellularComponent	SWI/SNF complex	ARID1B ARID1A	2.07e-03	30	47	2	GO:0016514
MousePheno	abnormal lateral semicircular canal morphology	CHD7 DLX5 FIGN	2.58e-05	21	39	3	MP:0000037
MousePheno	abnormal otic capsule morphology	CHD7 DLX5 FIGN	2.58e-05	21	39	3	MP:0000039
MousePheno	abnormal secondary palate morphology	TSHZ1 CHD7 DLX5 EYA4 FIGN	7.53e-05	159	39	5	MP:0013550
MousePheno	abnormal middle ear epithelium morphology	CHD7 EYA4	7.54e-05	5	39	2	MP:0020900
MousePheno	abnormal middle ear goblet cell morphology	CHD7 EYA4	7.54e-05	5	39	2	MP:0020901
MousePheno	abnormal middle ear goblet cell number	CHD7 EYA4	7.54e-05	5	39	2	MP:0020902
MousePheno	increased middle ear goblet cell number	CHD7 EYA4	7.54e-05	5	39	2	MP:0020903
MousePheno	abnormal temporal bone petrous part morphology	CHD7 DLX5 FIGN	9.42e-05	32	39	3	MP:0030319
MousePheno	abnormal malleus manubrium morphology	TSHZ1 CHD7	1.13e-04	6	39	2	MP:0008374
MousePheno	abnormal malleus morphology	TSHZ1 CHD7 DLX5	1.13e-04	34	39	3	MP:0000029
MousePheno	abnormal forebrain morphology	ROBO1 TCF4 SETD2 TSHZ1 ARID1B CHD7 DLX5 FUS TCF20 ARID1A PCSK6	1.16e-04	1072	39	11	MP:0000783
MousePheno	perinatal lethality, complete penetrance	ROBO1 TCF4 TSHZ1 ARID1B DLX5 EYA4 FUS ILF3 ARID1A	1.17e-04	712	39	9	MP:0011089
MousePheno	abnormal middle ear morphology	TSHZ1 CHD7 DLX5 EYA4	1.21e-04	92	39	4	MP:0000049
MousePheno	abnormal olfactory bulb granule cell layer morphology	TSHZ1 DLX5	1.58e-04	7	39	2	MP:0009949
MousePheno	decreased lateral semicircular canal size	CHD7 DLX5	1.58e-04	7	39	2	MP:0003162
MousePheno	abnormal head morphology	ROBO1 TCF4 SETD2 TSHZ1 CHD7 DLX5 EYA4 NF1 FIGN PCSK6 NSD3	1.71e-04	1120	39	11	MP:0000432
MousePheno	abnormal malleus processus brevis morphology	TSHZ1 DLX5	2.10e-04	8	39	2	MP:0010324
MousePheno	abnormal palate morphology	ROBO1 TSHZ1 CHD7 DLX5 EYA4 FIGN	2.41e-04	321	39	6	MP:0003755
MousePheno	abnormal auditory tube morphology	CHD7 EYA4	2.70e-04	9	39	2	MP:0003330
MousePheno	absent posterior semicircular canal	CHD7 DLX5	2.70e-04	9	39	2	MP:0003163
MousePheno	abnormal nasal pit morphology	CHD7 DLX5	2.70e-04	9	39	2	MP:0006306
MousePheno	abnormal telencephalon morphology	ROBO1 TCF4 TSHZ1 ARID1B CHD7 DLX5 FUS TCF20 PCSK6	3.15e-04	812	39	9	MP:0000787
MousePheno	abnormal outer ear morphology	TSHZ1 CHD7 DLX5 NF1	3.26e-04	119	39	4	MP:0002177
MousePheno	abnormal crista ampullaris neuroepithelium morphology	CHD7 DLX5	4.11e-04	11	39	2	MP:0004409
MousePheno	abnormal corpus callosum morphology	ROBO1 TCF4 ARID1B CHD7	4.43e-04	129	39	4	MP:0000780
MousePheno	aphagia	ROBO1 RFX6 TSHZ1 DLX5	4.43e-04	129	39	4	MP:0001438
MousePheno	abnormal nervous system development	ROBO1 TCF4 SETD2 ARID1B CHD7 DLX5 NF1 TCF20 ARID1A FIGN PCSK6	4.69e-04	1257	39	11	MP:0003861
MousePheno	abnormal dorsal telencephalic commissure morphology	ROBO1 TCF4 ARID1B CHD7	4.84e-04	132	39	4	MP:0008219
MousePheno	absent semicircular canals	DLX5 FIGN	4.92e-04	12	39	2	MP:0000036
MousePheno	abnormal middle ear ossicle morphology	TSHZ1 CHD7 DLX5	5.02e-04	56	39	3	MP:0005105
MousePheno	abnormal gonial bone morphology	TSHZ1 DLX5	5.80e-04	13	39	2	MP:0008380
MousePheno	absent lateral semicircular canal	CHD7 FIGN	5.80e-04	13	39	2	MP:0003161
MousePheno	abnormal semicircular canal morphology	CHD7 DLX5 FIGN	5.86e-04	59	39	3	MP:0002428
MousePheno	postnatal lethality	COL3A1 TCF4 RFX6 CHD7 DLX5 EYA4 FUS NF1 TCF20 FIGN	6.00e-04	1084	39	10	MP:0002082
MousePheno	neonatal lethality, complete penetrance	TCF4 TSHZ1 DLX5 EYA4 FUS ILF3 ARID1A	6.06e-04	534	39	7	MP:0011087
MousePheno	abnormal head development	SETD2 CHD7 DLX5	6.78e-04	62	39	3	MP:0012176
MousePheno	abnormal inner ear canal morphology	CHD7 DLX5 FIGN	7.10e-04	63	39	3	MP:0002729
MousePheno	abnormal facial morphology	ROBO1 TSHZ1 CHD7 DLX5 EYA4 NF1 FIGN PCSK6 NSD3	7.25e-04	910	39	9	MP:0003743
MousePheno	ventricular septal defect	ROBO1 CHD7 NF1 ARID1A PCSK6	7.48e-04	261	39	5	MP:0010402
MousePheno	abnormal olfactory lobe morphology	ROBO1 TSHZ1 CHD7 DLX5	7.63e-04	149	39	4	MP:0009944
MousePheno	small otic vesicle	CHD7 DLX5	7.78e-04	15	39	2	MP:0004310
MousePheno	abnormal temporal bone morphology	CHD7 DLX5 FIGN	8.14e-04	66	39	3	MP:0005272
MousePheno	effusion	SETD2 EYA4 NF1 ARID1A	8.22e-04	152	39	4	MP:0021205
MousePheno	abnormal hard palate morphology	CHD7 DLX5 EYA4	8.50e-04	67	39	3	MP:0003756
MousePheno	abnormal tympanic cavity morphology	DLX5 EYA4	8.88e-04	16	39	2	MP:0030154
MousePheno	abnormal superior semicircular canal morphology	CHD7 DLX5	8.88e-04	16	39	2	MP:0003069
MousePheno	decreased circulating aspartate transaminase level	CHD7 NF1 SYNGR2	9.26e-04	69	39	3	MP:0005632
MousePheno	small middle ear ossicles	TSHZ1 CHD7	1.00e-03	17	39	2	MP:0030123
MousePheno	abnormal social/conspecific interaction behavior	TCF4 ARID1B CHD7 DLX5 TCF20 FIGN	1.01e-03	421	39	6	MP:0002557
MousePheno	abnormal brain commissure morphology	ROBO1 TCF4 ARID1B CHD7	1.02e-03	161	39	4	MP:0002199
MousePheno	decreased enzyme/conezyme level	CP CHD7 NF1 KLHDC10 SYNGR2	1.09e-03	284	39	5	MP:0014449
MousePheno	abnormal nasal capsule morphology	DLX5 PCSK6	1.13e-03	18	39	2	MP:0004726
MousePheno	cleft palate	ROBO1 CHD7 DLX5 EYA4 FIGN	1.18e-03	289	39	5	MP:0000111
MousePheno	oral cleft	ROBO1 CHD7 DLX5 EYA4 FIGN	1.22e-03	291	39	5	MP:0021164
MousePheno	abnormal external auditory canal morphology	TSHZ1 DLX5	1.26e-03	19	39	2	MP:0006033
MousePheno	abnormal pharyngeal arch morphology	SETD2 CHD7 DLX5 PCSK6	1.27e-03	171	39	4	MP:0002884
MousePheno	decreased brain size	TCF4 SETD2 CHD7 TCF20 ARID1A	1.29e-03	295	39	5	MP:0000774
MousePheno	neonatal lethality	ROBO1 TCF4 TSHZ1 DLX5 EYA4 FUS ILF3 ARID1A	1.39e-03	799	39	8	MP:0002058
MousePheno	abnormal posterior semicircular canal morphology	CHD7 DLX5	1.40e-03	20	39	2	MP:0002858
MousePheno	abnormal pterygoid process morphology	DLX5 FIGN	1.54e-03	21	39	2	MP:0004452
MousePheno	decreased circulating alanine transaminase level	CHD7 NF1 SYNGR2	1.64e-03	84	39	3	MP:0002942
MousePheno	abnormal olfactory bulb layer morphology	TSHZ1 DLX5	1.69e-03	22	39	2	MP:0009946
MousePheno	head shaking	CHD7 FIGN	1.69e-03	22	39	2	MP:0002730
MousePheno	abnormal brain development	TCF4 ARID1B CHD7 DLX5 TCF20 FIGN PCSK6	1.71e-03	638	39	7	MP:0000913
MousePheno	abnormal ear morphology	TSHZ1 CHD7 DLX5 EYA4 NF1 FIGN	1.78e-03	470	39	6	MP:0002102
MousePheno	abnormal nervous system tract morphology	ROBO1 TCF4 ARID1B CHD7	1.84e-03	189	39	4	MP:0000778
MousePheno	forebrain hypoplasia	SETD2 ARID1A	2.01e-03	24	39	2	MP:0000784
MousePheno	bidirectional circling	CHD7 FIGN	2.01e-03	24	39	2	MP:0001395
MousePheno	lethality during fetal growth through weaning, complete penetrance	ROBO1 TCF4 TSHZ1 ARID1B DLX5 EYA4 FUS ILF3 NF1 ARID1A	2.02e-03	1269	39	10	MP:0011111
MousePheno	abnormal nasal cartilage morphology	DLX5 PCSK6	2.18e-03	25	39	2	MP:0031449
MousePheno	abnormal mouth morphology	ROBO1 TSHZ1 CHD7 DLX5 EYA4 NF1 FIGN	2.27e-03	670	39	7	MP:0000452
MousePheno	abnormal hypothalamus physiology	ARID1B CHD7	2.36e-03	26	39	2	MP:0005645
MousePheno	conjunctivitis	CHD7 FIGN	2.36e-03	26	39	2	MP:0001852
MousePheno	abnormal interventricular septum morphology	ROBO1 CHD7 NF1 ARID1A PCSK6	2.47e-03	342	39	5	MP:0000281
MousePheno	abnormal brain white matter morphology	ROBO1 TCF4 ARID1B CHD7	2.52e-03	206	39	4	MP:0008026
MousePheno	abnormal astrocyte physiology	CP NF1	2.55e-03	27	39	2	MP:0008916
MousePheno	abnormal crista ampullaris morphology	CHD7 DLX5	2.74e-03	28	39	2	MP:0004249
Domain	-	RBM5 EWSR1 TAF15 FUS RBM10	1.81e-11	10	46	5	4.10.1060.10
Domain	zf-RanBP	RBM5 EWSR1 TAF15 FUS RBM10	1.85e-09	22	46	5	PF00641
Domain	ZnF_RBZ	RBM5 EWSR1 TAF15 FUS RBM10	2.36e-09	23	46	5	SM00547
Domain	ZF_RANBP2_2	RBM5 EWSR1 TAF15 FUS RBM10	2.36e-09	23	46	5	PS50199
Domain	ZF_RANBP2_1	RBM5 EWSR1 TAF15 FUS RBM10	2.97e-09	24	46	5	PS01358
Domain	Znf_RanBP2	RBM5 EWSR1 TAF15 FUS RBM10	3.71e-09	25	46	5	IPR001876
Domain	BAF250_C	ARID1B ARID1A	5.93e-06	2	46	2	IPR033388
Domain	BAF250_C	ARID1B ARID1A	5.93e-06	2	46	2	PF12031
Domain	BAF250/Osa	ARID1B ARID1A	5.93e-06	2	46	2	IPR021906
Domain	AWS	SETD2 NSD3	5.91e-05	5	46	2	PS51215
Domain	AWS_dom	SETD2 NSD3	5.91e-05	5	46	2	IPR006560
Domain	AWS	SETD2 NSD3	5.91e-05	5	46	2	SM00570
Domain	RRM_1	RBM5 EWSR1 TAF15 FUS RBM10	1.54e-04	208	46	5	PF00076
Domain	RRM	RBM5 EWSR1 TAF15 FUS RBM10	1.88e-04	217	46	5	SM00360
Domain	RRM_dom	RBM5 EWSR1 TAF15 FUS RBM10	2.32e-04	227	46	5	IPR000504
Domain	RRM	RBM5 EWSR1 TAF15 FUS RBM10	2.46e-04	230	46	5	PS50102
Domain	-	RBM5 EWSR1 TAF15 FUS RBM10	3.23e-04	244	46	5	3.30.70.330
Domain	Nucleotide-bd_a/b_plait	RBM5 EWSR1 TAF15 FUS RBM10	4.18e-04	258	46	5	IPR012677
Domain	-	ARID1B ARID1A	6.11e-04	15	46	2	1.10.150.60
Domain	ARID	ARID1B ARID1A	6.11e-04	15	46	2	PF01388
Domain	BRIGHT	ARID1B ARID1A	6.11e-04	15	46	2	SM00501
Domain	ARID_dom	ARID1B ARID1A	6.11e-04	15	46	2	IPR001606
Domain	ARID	ARID1B ARID1A	6.11e-04	15	46	2	PS51011
Domain	Post-SET_dom	SETD2 NSD3	6.97e-04	16	46	2	IPR003616
Domain	PostSET	SETD2 NSD3	6.97e-04	16	46	2	SM00508
Domain	POST_SET	SETD2 NSD3	6.97e-04	16	46	2	PS50868
Domain	G_patch	RBM5 RBM10	1.45e-03	23	46	2	SM00443
Domain	G_patch_dom	RBM5 RBM10	1.45e-03	23	46	2	IPR000467
Domain	G-patch	RBM5 RBM10	1.45e-03	23	46	2	PF01585
Domain	G_PATCH	RBM5 RBM10	1.45e-03	23	46	2	PS50174
Domain	MARVEL	SYNPR SYNGR2	2.00e-03	27	46	2	PF01284
Domain	MARVEL	SYNPR SYNGR2	2.15e-03	28	46	2	PS51225
Domain	Marvel	SYNPR SYNGR2	2.15e-03	28	46	2	IPR008253
Domain	SET	SETD2 NSD3	4.58e-03	41	46	2	PF00856
Domain	Znf_FYVE_PHD	TCF20 PCLO NSD3	5.66e-03	147	46	3	IPR011011
Domain	SET	SETD2 NSD3	5.73e-03	46	46	2	SM00317
Domain	SET_dom	SETD2 NSD3	6.74e-03	50	46	2	IPR001214
Domain	SET	SETD2 NSD3	6.74e-03	50	46	2	PS50280
Domain	Homeodomain-like	TCF4 TSHZ1 DLX5 IRX2	8.90e-03	332	46	4	IPR009057
Pathway	WP_MRNA_PROCESSING	RBM5 SECISBP2 EWSR1 TAF15 FUS ILF3 RBM10 DDX5	1.13e-05	451	35	8	MM15946
Pubmed	FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex.	EWSR1 TAF15 ARID1B FUS ARID1A	1.20e-10	23	47	5	30962207
Pubmed	DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity.	RBM5 SETD2 EWSR1 TAF15 ARID1B FUS ILF3 TCF20 ARID1A RBM10	4.29e-10	453	47	10	29656893
Pubmed	Identifying and quantifying in vivo methylation sites by heavy methyl SILAC.	EWSR1 TAF15 FUS ILF3 DDX5	5.03e-10	30	47	5	15782174
Pubmed	The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	18620564
Pubmed	mRNA and protein levels of FUS, EWSR1, and TAF15 are upregulated in liposarcoma.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	21344536
Pubmed	A conserved N-terminal motif is required for complex formation between FUS, EWSR1, TAF15 and their oncogenic fusion proteins.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	23975937
Pubmed	Aggregation of FET Proteins as a Pathological Change in Amyotrophic Lateral Sclerosis.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	27311318
Pubmed	FET proteins TAF15 and EWS are selective markers that distinguish FTLD with FUS pathology from amyotrophic lateral sclerosis with FUS mutations.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	21856723
Pubmed	Role of FET proteins in neurodegenerative disorders.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	27415968
Pubmed	O-GlcNAc glycosylation stoichiometry of the FET protein family: only EWS is glycosylated with a high stoichiometry.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	27903134
Pubmed	Characterization of a new brain-specific isoform of the EWS oncoprotein.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	11422378
Pubmed	Gene expression responses to FUS, EWS, and TAF15 reduction and stress granule sequestration analyses identifies FET-protein non-redundant functions.	EWSR1 TAF15 FUS	2.31e-09	3	47	3	23049996
Pubmed	mTORC1 activity regulates post-translational modifications of glycine decarboxylase to modulate glycine metabolism and tumorigenesis.	RBM5 EWSR1 FUS ILF3 TCF20 RBM10 DDX5 BAG4	3.23e-09	274	47	8	34244482
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	SETD2 EWSR1 TAF15 ARID1B CHD7 FUS ILF3 TCF20 ARID1A RBM10 DDX5 NSD3	3.66e-09	954	47	12	36373674
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	EWSR1 TAF15 CHD7 FUS ILF3 TCF20 RBM10 DDX5	4.16e-09	283	47	8	30585729
Pubmed	Loss of TRIM31 promotes breast cancer progression through regulating K48- and K63-linked ubiquitination of p53.	CP SETD2 EWSR1 TAF15 EYA4 FUS ILF3 DDX5 BAG4	4.65e-09	421	47	9	34650049
Pubmed	Post-transcriptional regulation of FUS and EWS protein expression by miR-141 during neural differentiation.	EWSR1 TAF15 FUS	9.24e-09	4	47	3	28453628
Pubmed	The neurodegenerative diseases ALS and SMA are linked at the molecular level via the ASC-1 complex.	EWSR1 TAF15 FUS	9.24e-09	4	47	3	30398641
Pubmed	The transcriptional repressor ZFM1 interacts with and modulates the ability of EWS to activate transcription.	EWSR1 TAF15 FUS	9.24e-09	4	47	3	9660765
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RBM5 SETD2 EWSR1 TAF15 CHD7 EYA4 FUS ILF3 TCF20 ARID1A RBM10 DDX5 NSD3	1.07e-08	1294	47	13	30804502
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	RBM5 SETD2 EWSR1 TAF15 ARID1B CHD7 ILF3 TCF20 ARID1A RBM10 DDX5 NSD3	1.48e-08	1082	47	12	38697112
Pubmed	Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription.	EWSR1 TAF15 FUS	4.61e-08	6	47	3	18509338
Pubmed	The hnRNP RALY regulates PRMT1 expression and interacts with the ALS-linked protein FUS: implication for reciprocal cellular localization.	EWSR1 TAF15 FUS	4.61e-08	6	47	3	30354839
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RBM5 EWSR1 NOL4L ARID1B CHD7 FUS ILF3 TCF20 ARID1A RBM10 DDX5	1.90e-07	1103	47	11	34189442
Pubmed	Congenital Diaphragmatic Hernia Overview	COL3A1 ARID1B CHD7 ARID1A	4.58e-07	46	47	4	20301533
Pubmed	ZF21 is a new regulator of focal adhesion disassembly and a potential member of the spreading initiation center.	EWSR1 TAF15 FUS DDX5	4.58e-07	46	47	4	20890123
Pubmed	Composition and three-dimensional EM structure of double affinity-purified, human prespliceosomal A complexes.	RBM5 FUS ILF3 RBM10 DDX5	4.97e-07	115	47	5	17332742
Pubmed	Nucleolar localization of DGCR8 and identification of eleven DGCR8-associated proteins.	FUS ILF3 DDX5	6.55e-07	13	47	3	17765891
Pubmed	Interactome analyses revealed that the U1 snRNP machinery overlaps extensively with the RNAP II machinery and contains multiple ALS/SMA-causative proteins.	EWSR1 TAF15 FUS ILF3 RBM10 DDX5	9.46e-07	244	47	6	29884807
Pubmed	BioID identifies novel c-MYC interacting partners in cultured cells and xenograft tumors.	ARID1B FUS TCF20 ARID1A RBM10	1.06e-06	134	47	5	25452129
Pubmed	Landscape of the SOX2 protein-protein interactome.	EWSR1 TAF15 FUS ILF3 DDX5	1.14e-06	136	47	5	21280222
Pubmed	CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality.	RBM5 EWSR1 TAF15 FUS ILF3 ARID1A RBM10 DDX5	1.39e-06	605	47	8	28977666
Pubmed	EWS-FLI1 modulated alternative splicing of ARID1A reveals novel oncogenic function through the BAF complex.	EWSR1 ARID1A	1.79e-06	2	47	2	31392992
Pubmed	Dual ARID1A/ARID1B loss leads to rapid carcinogenesis and disruptive redistribution of BAF complexes.	ARID1B ARID1A	1.79e-06	2	47	2	34386776
Pubmed	Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.	ARID1B ARID1A	1.79e-06	2	47	2	23202128
Pubmed	ARID1 proteins: from transcriptional and post-translational regulation to carcinogenesis and potential therapeutics.	ARID1B ARID1A	1.79e-06	2	47	2	33890484
Pubmed	RBM10 promotes transformation-associated processes in small cell lung cancer and is directly regulated by RBM5.	RBM5 RBM10	1.79e-06	2	47	2	28662214
Pubmed	Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis.	EWSR1 TAF15	1.79e-06	2	47	2	22454397
Pubmed	Expression patterns of the human sarcoma-associated genes FUS and EWS and the genomic structure of FUS.	EWSR1 FUS	1.79e-06	2	47	2	8921363
Pubmed	ARID1B is a specific vulnerability in ARID1A-mutant cancers.	ARID1B ARID1A	1.79e-06	2	47	2	24562383
Pubmed	EWS and FUS bind a subset of transcribed genes encoding proteins enriched in RNA regulatory functions.	EWSR1 FUS	1.79e-06	2	47	2	26573619
Pubmed	Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.	TAF15 FUS	1.79e-06	2	47	2	9795213
Pubmed	Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.	RBM5 RBM10	1.79e-06	2	47	2	28586478
Pubmed	Cloning and mapping of a human RBP56 gene encoding a putative RNA binding protein similar to FUS/TLS and EWS proteins.	EWSR1 TAF15	1.79e-06	2	47	2	8954779
Pubmed	Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis.	ARID1B ARID1A	1.79e-06	2	47	2	37611161
Pubmed	Subunits of ARID1 serve as novel biomarkers for the sensitivity to immune checkpoint inhibitors and prognosis of advanced non-small cell lung cancer.	ARID1B ARID1A	1.79e-06	2	47	2	32791957
Pubmed	Identification of SETD2-NF1 fusion gene in a pediatric spindle cell tumor with the chromosomal translocation t(3;17)(p21;q12).	SETD2 NF1	1.79e-06	2	47	2	28498454
Pubmed	ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma.	ARID1B ARID1A	1.79e-06	2	47	2	29890703
Pubmed	SWI/SNF factors required for cellular resistance to DNA damage include ARID1A and ARID1B and show interdependent protein stability.	ARID1B ARID1A	1.79e-06	2	47	2	24788099
Pubmed	Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers.	ARID1B ARID1A	1.79e-06	2	47	2	28967863
Pubmed	Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.	ARID1B ARID1A	1.79e-06	2	47	2	33052929
Pubmed	Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas.	ARID1B ARID1A	1.79e-06	2	47	2	27562491
Pubmed	A morphologic and molecular reappraisal of myoepithelial tumors of soft tissue, bone, and viscera with EWSR1 and FUS gene rearrangements.	EWSR1 FUS	1.79e-06	2	47	2	31994243
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	SETD2 ARID1B FUS ILF3 NF1 ARID1A RBM10	2.01e-06	440	47	7	34244565
Pubmed	Histone-binding of DPF2 mediates its repressive role in myeloid differentiation.	EWSR1 TAF15 ARID1B FUS ARID1A DDX5	2.23e-06	283	47	6	28533407
Pubmed	Multiple myeloma-associated chromosomal translocation activates orphan snoRNA ACA11 to suppress oxidative stress.	EWSR1 FUS ILF3 RBM10 DDX5	2.46e-06	159	47	5	22751105
Pubmed	Agonist-specific Protein Interactomes of Glucocorticoid and Androgen Receptor as Revealed by Proximity Mapping.	ARID1B CHD7 TCF20 ARID1A	3.88e-06	78	47	4	28611094
Pubmed	Identification of proteins interacting with protein arginine methyltransferase 8: the Ewing sarcoma (EWS) protein binds independent of its methylation state.	EWSR1 TAF15 FUS	4.02e-06	23	47	3	18320585
Pubmed	Identification of the SOX2 Interactome by BioID Reveals EP300 as a Mediator of SOX2-dependent Squamous Differentiation and Lung Squamous Cell Carcinoma Growth.	ARID1B CHD7 TCF20 ARID1A	4.97e-06	83	47	4	28794006
Pubmed	Loss of ARID1B and SMARCB1 expression are specific for the diagnosis of dedifferentiated/undifferentiated carcinoma in tumours of the upper gynaecological tract and cervix.	ARID1B ARID1A	5.36e-06	3	47	2	33432679
Pubmed	FUS-NFATC2 or EWSR1-NFATC2 Fusions Are Present in a Large Proportion of Simple Bone Cysts.	EWSR1 FUS	5.36e-06	3	47	2	32991339
Pubmed	Selective interactions of hnRNP M isoforms with the TET proteins TAF15 and TLS/FUS.	TAF15 FUS	5.36e-06	3	47	2	24474660
Pubmed	Dynamics of expression of ARID1A and ARID1B subunits in mouse embryos and in cells during the cell cycle.	ARID1B ARID1A	5.36e-06	3	47	2	21647563
Pubmed	TNPO1-mediated nuclear import of ARID1B promotes tumor growth in ARID1A-deficient gynecologic cancer.	ARID1B ARID1A	5.36e-06	3	47	2	34044070
Pubmed	Genome-Wide Transcriptional Regulation Mediated by Biochemically Distinct SWI/SNF Complexes.	ARID1B ARID1A	5.36e-06	3	47	2	26716708
Pubmed	Recurrent rearrangement of the Ewing's sarcoma gene, EWSR1, or its homologue, TAF15, with the transcription factor CIZ/NMP4 in acute leukemia.	EWSR1 TAF15	5.36e-06	3	47	2	12359745
Pubmed	Co- and post-transcriptional regulation of Rbm5 and Rbm10 in mouse cells as evidenced by tissue-specific, developmental and disease-associated variation of splice variant and protein expression levels.	RBM5 RBM10	5.36e-06	3	47	2	26784654
Pubmed	A Subset of Malignant Mesotheliomas in Young Adults Are Associated With Recurrent EWSR1/FUS-ATF1 Fusions.	EWSR1 FUS	5.36e-06	3	47	2	28505004
Pubmed	Unclassified low grade spindle cell sarcoma with storiform pattern characterized by recurrent novel EWSR1/FUS-NACC1 fusions.	EWSR1 FUS	5.36e-06	3	47	2	33859361
Pubmed	Novel FUS-KLF17 and EWSR1-KLF17 fusions in myoepithelial tumors.	EWSR1 FUS	5.36e-06	3	47	2	25706482
Pubmed	NR4A3 fusion proteins trigger an axon guidance switch that marks the difference between EWSR1 and TAF15 translocated extraskeletal myxoid chondrosarcomas.	EWSR1 TAF15	5.36e-06	3	47	2	31020999
Pubmed	Ewing sarcoma with ERG gene rearrangements: A molecular study focusing on the prevalence of FUS-ERG and common pitfalls in detecting EWSR1-ERG fusions by FISH.	EWSR1 FUS	5.36e-06	3	47	2	26690869
Pubmed	Cytokeratin-positive Malignant Tumor in the Abdomen With EWSR1/FUS-CREB Fusion: A Clinicopathologic Study of 8 Cases.	EWSR1 FUS	5.36e-06	3	47	2	34049318
Pubmed	Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome.	ARID1B ARID1A	5.36e-06	3	47	2	22426308
Pubmed	Exome sequencing reveals frequent inactivating mutations in ARID1A, ARID1B, ARID2 and ARID4A in microsatellite unstable colorectal cancer.	ARID1B ARID1A	5.36e-06	3	47	2	24382590
Pubmed	Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions.	EWSR1 FUS	5.36e-06	3	47	2	38168093
Pubmed	Proteomic analysis of FUS interacting proteins provides insights into FUS function and its role in ALS.	TAF15 FUS	5.36e-06	3	47	2	27460707
Pubmed	ARID1A, ARID1B, and ARID2 Mutations Serve as Potential Biomarkers for Immune Checkpoint Blockade in Patients With Non-Small Cell Lung Cancer.	ARID1B ARID1A	5.36e-06	3	47	2	34512623
Pubmed	Revealing A-Raf functions through its interactome.	EWSR1 TAF15 FUS ILF3 DDX5	5.44e-06	187	47	5	29777862
Pubmed	ARIH2 Is a Vif-Dependent Regulator of CUL5-Mediated APOBEC3G Degradation in HIV Infection.	EWSR1 TAF15 FUS ILF3 KLHDC10 BAG4	5.98e-06	336	47	6	31253590
Pubmed	PRP19 transforms into a sensor of RPA-ssDNA after DNA damage and drives ATR activation via a ubiquitin-mediated circuitry.	EWSR1 TAF15 FUS ILF3 RBM10 DDX5	6.40e-06	340	47	6	24332808
Pubmed	Blocking PPARγ interaction facilitates Nur77 interdiction of fatty acid uptake and suppresses breast cancer progression.	TAF15 EYA4 DDX5 BAG4	6.87e-06	90	47	4	33087562
Pubmed	A genome-wide in situ hybridization map of RNA-binding proteins reveals anatomically restricted expression in the developing mouse brain.	RBM5 EWSR1 TAF15 FUS ILF3 RBM10	7.19e-06	347	47	6	16033648
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	SEC16B SETD2 NOL4L CHD7 ILF3 NF1 TCF20 RBM10	8.47e-06	774	47	8	15302935
Pubmed	Arginine methylation and ubiquitylation crosstalk controls DNA end-resection and homologous recombination repair.	RBM5 EWSR1 TAF15 FUS ILF3 RBM10 DDX5	8.76e-06	551	47	7	34728620
Pubmed	Targeted DNA Sequencing from Autism Spectrum Disorder Brains Implicates Multiple Genetic Mechanisms.	SETD2 ARID1B	1.07e-05	4	47	2	26637798
Pubmed	RBM5, 6, and 10 differentially regulate NUMB alternative splicing to control cancer cell proliferation.	RBM5 RBM10	1.07e-05	4	47	2	24332178
Pubmed	Characterization of TFG in mus musculus and Caenorhabditis elegans.	EWSR1 FUS	1.07e-05	4	47	2	10092511
Pubmed	Potentiated Hsp104 variants suppress toxicity of diverse neurodegenerative disease-linked proteins.	TAF15 FUS	1.07e-05	4	47	2	25062688
Pubmed	Undifferentiated Endometrial Carcinomas Show Frequent Loss of Core Switch/Sucrose Nonfermentable Complex Proteins.	ARID1B ARID1A	1.07e-05	4	47	2	28863077
Pubmed	Two related ARID family proteins are alternative subunits of human SWI/SNF complexes.	ARID1B ARID1A	1.07e-05	4	47	2	15170388
Pubmed	Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein.	ARID1B ARID1A	1.07e-05	4	47	2	11988099
Pubmed	TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation.	ARID1B TCF20 ARID1A RBM10 DDX5	1.20e-05	220	47	5	35785414
Pubmed	Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice.	CHD7 FUS ILF3 NF1 ARID1A RBM10 DDX5	1.25e-05	582	47	7	20467437
Pubmed	TWIST1 and chromatin regulatory proteins interact to guide neural crest cell differentiation.	TCF4 CHD7 TCF20 NSD3	1.47e-05	109	47	4	33554859
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	RBM5 FUS ILF3 RBM10 BAG4	1.54e-05	232	47	5	25515538
Pubmed	Identification and functional characterization of transcriptional activators in human cells.	TSHZ1 ARID1B CHD7 TCF20 ARID1A PCLO	1.56e-05	398	47	6	35016035
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	SETD2 EWSR1 TAF15 FUS ILF3 RBM10	1.58e-05	399	47	6	35987950
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	RBM5 EWSR1 TAF15 FUS ILF3 RBM10 DDX5 NSD3	1.62e-05	847	47	8	35850772
Pubmed	Human transcription factor protein interaction networks.	TCF4 EWSR1 NOL4L ARID1B CHD7 EYA4 TCF20 ARID1A FIGN RBM10	1.71e-05	1429	47	10	35140242
Interaction	SNRNP40 interactions	RBM5 SETD2 EWSR1 TAF15 ARID1B FUS ILF3 TCF20 ARID1A FIGN RBM10 DDX5 NSD3	1.09e-09	637	46	13	int:SNRNP40
Interaction	SNRPC interactions	SETD2 RFX6 EWSR1 TAF15 EYA4 FUS ILF3 RBM10 DDX5 BAG4	4.49e-08	440	46	10	int:SNRPC
Interaction	CELF1 interactions	RBM5 SECISBP2 EWSR1 TAF15 FUS ILF3 RBM10 DDX5	2.57e-07	288	46	8	int:CELF1
Interaction	FLI1 interactions	EWSR1 TAF15 ARID1B FUS ARID1A	2.91e-07	62	46	5	int:FLI1
Interaction	PAX9 interactions	EWSR1 ARID1B CHD7 TCF20 ARID1A FIGN	4.86e-07	130	46	6	int:PAX9
Interaction	GLDC interactions	RBM5 EWSR1 FUS ILF3 TCF20 RBM10 DDX5 BAG4	5.85e-07	321	46	8	int:GLDC
Interaction	MECP2 interactions	RBM5 SETD2 EWSR1 TAF15 ARID1B CHD7 DLX5 FUS ILF3 TCF20 ARID1A RBM10 DDX5 NSD3	6.07e-07	1287	46	14	int:MECP2
Interaction	TRIM31 interactions	CP SETD2 EWSR1 TAF15 EYA4 FUS ILF3 DDX5 BAG4	7.26e-07	454	46	9	int:TRIM31
Interaction	SMARCA4 interactions	EWSR1 TAF15 ARID1B CHD7 FUS NF1 ARID1A DDX5 NSD3	8.39e-07	462	46	9	int:SMARCA4
Interaction	SOX7 interactions	EWSR1 ARID1B CHD7 TCF20 ARID1A	1.19e-06	82	46	5	int:SOX7
Interaction	SMC5 interactions	SETD2 EWSR1 TAF15 ARID1B CHD7 FUS ILF3 TCF20 ARID1A RBM10 DDX5 NSD3	1.70e-06	1000	46	12	int:SMC5
Interaction	SOX10 interactions	TCF4 ARID1B CHD7 DLX5 ARID1A	2.10e-06	92	46	5	int:SOX10
Interaction	SOX17 interactions	ARID1B CHD7 ILF3 TCF20 ARID1A	2.46e-06	95	46	5	int:SOX17
Interaction	DCUN1D1 interactions	EWSR1 TAF15 FUS ILF3 KLHDC10 DDX5 BAG4	2.77e-06	275	46	7	int:DCUN1D1
Interaction	SS18L1 interactions	RFX6 ARID1B ARID1A NSD3 BAG4	2.87e-06	98	46	5	int:SS18L1
Interaction	SUPT5H interactions	TAF15 ARID1B CHD7 EYA4 FUS TCF20 ARID1A DDX5	3.51e-06	408	46	8	int:SUPT5H
Interaction	SF1 interactions	EWSR1 TAF15 EYA4 FUS ILF3 RBM10 BAG4	5.36e-06	304	46	7	int:SF1
Interaction	SP7 interactions	ARID1B CHD7 DLX5 EYA4 TCF20 ARID1A RBM10	5.36e-06	304	46	7	int:SP7
Interaction	CUL2 interactions	EWSR1 TAF15 ARID1B FUS ILF3 KLHDC10 ARID1A DDX5 BAG4	6.31e-06	591	46	9	int:CUL2
Interaction	SCARNA22 interactions	EWSR1 FUS ILF3 RBM10 DDX5	7.15e-06	118	46	5	int:SCARNA22
Interaction	DDIT3 interactions	EWSR1 TAF15 ARID1B FUS ARID1A	7.76e-06	120	46	5	int:DDIT3
Interaction	MYCN interactions	TCF4 SETD2 EWSR1 TAF15 ARID1B CHD7 FUS ILF3 TCF20 KLHDC10 ARID1A RBM10 DDX5	7.85e-06	1373	46	13	int:MYCN
Interaction	DTX2 interactions	RFX6 EWSR1 EYA4 FCRL4 TCF20 RBM10 DDX5	9.16e-06	330	46	7	int:DTX2
Interaction	ERG interactions	ARID1B CHD7 ILF3 TCF20 ARID1A DDX5	1.11e-05	223	46	6	int:ERG
Interaction	SNRPA interactions	SETD2 EWSR1 TAF15 FUS ILF3 RBM10 DDX5 BAG4	1.19e-05	482	46	8	int:SNRPA
Interaction	SMARCC2 interactions	TCF4 EWSR1 TAF15 ARID1B CHD7 FUS ARID1A	1.42e-05	353	46	7	int:SMARCC2
Interaction	RNU1-1 interactions	EWSR1 TAF15 FUS	1.44e-05	21	46	3	int:RNU1-1
Interaction	MEN1 interactions	RBM5 EWSR1 TAF15 ARID1B FUS ILF3 TCF20 ARID1A RBM10 DDX5 NSD3	1.50e-05	1029	46	11	int:MEN1
Interaction	BICRA interactions	EWSR1 ARID1B EYA4 ARID1A	1.64e-05	67	46	4	int:BICRA
Interaction	SNRPB interactions	SETD2 RFX6 EWSR1 TAF15 FUS ILF3 DDX5 BAG4	1.97e-05	517	46	8	int:SNRPB
Interaction	TLE3 interactions	TCF4 SETD2 TAF15 ARID1B TCF20 ARID1A FIGN	2.13e-05	376	46	7	int:TLE3
Interaction	CPSF6 interactions	SETD2 EWSR1 TAF15 EYA4 FUS ILF3 RBM10 DDX5	2.23e-05	526	46	8	int:CPSF6
Interaction	H2BC21 interactions	TAF15 ARID1B CHD7 FUS ILF3 TCF20 ARID1A PCLO NSD3	2.33e-05	696	46	9	int:H2BC21
Interaction	SMARCC1 interactions	EWSR1 TAF15 ARID1B CHD7 FUS ARID1A NSD3	2.44e-05	384	46	7	int:SMARCC1
Interaction	TP53BP1 interactions	RBM5 EWSR1 TAF15 ARID1B FUS ILF3 ARID1A RBM10	2.45e-05	533	46	8	int:TP53BP1
Interaction	NEDD8 interactions	EWSR1 TAF15 FUS ILF3 KLHDC10 DDX5 BAG4	2.82e-05	393	46	7	int:NEDD8
Interaction	RBM14 interactions	RBM5 TAF15 EYA4 FUS ILF3 RBM10 DDX5 BAG4	3.18e-05	553	46	8	int:RBM14
Interaction	TAF15 interactions	EWSR1 TAF15 FUS ILF3 ARID1A RBM10 DDX5	3.59e-05	408	46	7	int:TAF15
Interaction	ARID1A interactions	EWSR1 TAF15 ARID1B CHD7 FUS ARID1A	3.70e-05	276	46	6	int:ARID1A
Interaction	GATA4 interactions	EWSR1 TAF15 CHD7 FUS ILF3 ARID1A DDX5	3.76e-05	411	46	7	int:GATA4
Interaction	MDC1 interactions	SETD2 EWSR1 ARID1B FUS TCF20 ARID1A RBM10	3.93e-05	414	46	7	int:MDC1
Interaction	ZFYVE21 interactions	EWSR1 TAF15 FUS DDX5	4.01e-05	84	46	4	int:ZFYVE21
Interaction	CHD4 interactions	RBM5 EWSR1 NOL4L TAF15 FUS ILF3 TCF20 ARID1A RBM10 DDX5	4.02e-05	938	46	10	int:CHD4
Interaction	TWIST1 interactions	TCF4 CHD7 ILF3 TCF20 NSD3	4.17e-05	170	46	5	int:TWIST1
Interaction	IRF4 interactions	ARID1B CHD7 TCF20 ARID1A	4.20e-05	85	46	4	int:IRF4
Interaction	NUP35 interactions	EWSR1 ARID1B FUS ILF3 TCF20 ARID1A DDX5	4.58e-05	424	46	7	int:NUP35
Interaction	POU5F1 interactions	TCF4 EWSR1 ARID1B CHD7 ILF3 TCF20 ARID1A DDX5	4.68e-05	584	46	8	int:POU5F1
Interaction	DDX17 interactions	RBM5 EWSR1 TAF15 FUS ILF3 RBM10 DDX5	4.71e-05	426	46	7	int:DDX17
Interaction	RNF43 interactions	SECISBP2 ILF3 TCF20 ARID1A RBM10 DDX5 BAG4	4.79e-05	427	46	7	int:RNF43
Interaction	TLX1 interactions	ARID1B CHD7 EYA4 TCF20 ARID1A	4.79e-05	175	46	5	int:TLX1
Interaction	SOX2 interactions	RBM5 CP SETD2 EWSR1 TAF15 ARID1B CHD7 FUS ILF3 TCF20 ARID1A DDX5	5.95e-05	1422	46	12	int:SOX2
Interaction	HNF1B interactions	EWSR1 ARID1B CHD7 EYA4 ARID1A	7.08e-05	190	46	5	int:HNF1B
Interaction	SMG7 interactions	RBM5 SECISBP2 ARID1B TCF20 ARID1A RBM10	8.25e-05	319	46	6	int:SMG7
Interaction	MIRLET7D interactions	RBM5 TAF15 FUS RBM10	8.25e-05	101	46	4	int:MIRLET7D
Interaction	CEBPA interactions	RBM5 EWSR1 NOL4L ARID1B CHD7 FUS ILF3 TCF20 ARID1A RBM10 DDX5	8.59e-05	1245	46	11	int:CEBPA
Interaction	RUNX1 interactions	EWSR1 TAF15 FUS ARID1A DDX5 BAG4	8.98e-05	324	46	6	int:RUNX1
Interaction	SUZ12 interactions	RBM5 EWSR1 TAF15 CHD7 FUS ILF3 NF1 DDX5	9.28e-05	644	46	8	int:SUZ12
Interaction	MIRLET7E interactions	RBM5 TAF15 FUS RBM10	9.95e-05	106	46	4	int:MIRLET7E
Interaction	DDX23 interactions	RBM5 SETD2 EWSR1 TAF15 FUS RBM10 DDX5	9.97e-05	480	46	7	int:DDX23
Interaction	NR4A1 interactions	TCF4 TAF15 EYA4 DDX5 BAG4	1.19e-04	212	46	5	int:NR4A1
Interaction	SF3B4 interactions	EWSR1 EYA4 FUS ILF3 RBM10 BAG4	1.21e-04	342	46	6	int:SF3B4
Interaction	DHX15 interactions	RBM5 EWSR1 TAF15 FUS ILF3 RBM10 DDX5	1.32e-04	502	46	7	int:DHX15
Interaction	MIRLET7I interactions	RBM5 TAF15 FUS RBM10	1.32e-04	114	46	4	int:MIRLET7I
Interaction	SRSF6 interactions	RBM5 SETD2 EWSR1 TAF15 FUS NF1 RBM10	1.33e-04	503	46	7	int:SRSF6
Interaction	CMTR1 interactions	RBM5 TCF4 FUS ILF3 DDX5	1.35e-04	218	46	5	int:CMTR1
Interaction	TBXT interactions	ARID1B CHD7 TCF20 ARID1A	1.41e-04	116	46	4	int:TBXT
Interaction	MIRLET7G interactions	RBM5 TAF15 FUS RBM10	1.46e-04	117	46	4	int:MIRLET7G
Interaction	YAP1 interactions	SETD2 ARID1B FUS NF1 TCF20 ARID1A RBM10 DDX5 NSD3 BAG4	1.46e-04	1095	46	10	int:YAP1
Interaction	ZNF326 interactions	EWSR1 TAF15 FUS ILF3 DDX5	1.53e-04	224	46	5	int:ZNF326
Interaction	TOP1 interactions	SETD2 TAF15 ILF3 NF1 TCF20 ARID1A RBM10 DDX5	1.59e-04	696	46	8	int:TOP1
Interaction	EWSR1 interactions	EWSR1 TAF15 EYA4 FUS ILF3 TCF20 ARID1A PCLO DDX5	1.77e-04	906	46	9	int:EWSR1
Interaction	HNRNPAB interactions	EWSR1 TAF15 FUS ILF3 PCLO DDX5	1.88e-04	371	46	6	int:HNRNPAB
Interaction	POLR2A interactions	SETD2 EWSR1 TAF15 FUS ILF3 NF1 DDX5	1.97e-04	536	46	7	int:POLR2A
Interaction	ARAF interactions	SETD2 EWSR1 TAF15 FUS ILF3 DDX5	2.02e-04	376	46	6	int:ARAF
Interaction	XRCC6 interactions	TCF4 EWSR1 TAF15 CHD7 FUS ILF3 TCF20 RBM10 DDX5	2.12e-04	928	46	9	int:XRCC6
Interaction	KHDRBS2 interactions	EWSR1 ILF3 RBM10 DDX5	2.12e-04	129	46	4	int:KHDRBS2
Interaction	SMAD1 interactions	COL3A1 EWSR1 TCF20 ARID1A DDX5	2.24e-04	243	46	5	int:SMAD1
Interaction	ASF1A interactions	ARID1B CHD7 TCF20 ARID1A NSD3	2.51e-04	249	46	5	int:ASF1A
Interaction	DDX5 interactions	TCF4 EWSR1 TAF15 FUS ILF3 RBM10 DDX5	2.81e-04	568	46	7	int:DDX5
Interaction	CHD3 interactions	RBM5 EWSR1 TAF15 FUS ILF3 ARID1A RBM10 DDX5	2.81e-04	757	46	8	int:CHD3
Interaction	ABL1 interactions	ROBO1 EWSR1 FUS ILF3 DDX5	3.01e-04	259	46	5	int:ABL1
Interaction	TLX2 interactions	ARID1B CHD7 TCF20 ARID1A	3.06e-04	142	46	4	int:TLX2
Interaction	DAZL interactions	SECISBP2 TAF15 ILF3 ZCCHC2	3.32e-04	145	46	4	int:DAZL
Interaction	ELF5 interactions	ARID1B CHD7 ILF3 ARID1A	3.49e-04	147	46	4	int:ELF5
Interaction	PPIL1 interactions	TCF4 EWSR1 FUS DDX5	3.49e-04	147	46	4	int:PPIL1
Interaction	SF3A2 interactions	RBM5 FUS ILF3 RBM10 DDX5	3.83e-04	273	46	5	int:SF3A2
Interaction	CREBBP interactions	RBM5 EWSR1 ARID1B EYA4 FUS ARID1A DDX5	3.87e-04	599	46	7	int:CREBBP
Interaction	ARID2 interactions	ARID1B CHD7 FUS ARID1A	4.07e-04	153	46	4	int:ARID2
Interaction	SMARCE1 interactions	TCF4 EWSR1 ARID1B CHD7 ARID1A	4.81e-04	287	46	5	int:SMARCE1
Interaction	TLE5 interactions	TCF4 RFX6 EYA4 IRX2 RBM10 BAG4	4.85e-04	443	46	6	int:TLE5
Interaction	SIRT6 interactions	SETD2 ARID1B FUS ILF3 NF1 ARID1A RBM10	5.13e-04	628	46	7	int:SIRT6
Interaction	MSC interactions	TCF4 EWSR1	5.25e-04	15	46	2	int:MSC
Interaction	TCF3 interactions	TCF4 TAF15 EYA4 DDX5 NSD3	5.45e-04	295	46	5	int:TCF3
Interaction	LHX4 interactions	TCF4 ARID1B CHD7 ARID1A	5.53e-04	166	46	4	int:LHX4
Interaction	WWP2 interactions	EWSR1 TAF15 ARID1B ILF3 ARID1A RBM10 DDX5 BAG4	5.63e-04	840	46	8	int:WWP2
Interaction	CDC5L interactions	RBM5 TAF15 FUS ILF3 NF1 ARID1A RBM10 DDX5	6.32e-04	855	46	8	int:CDC5L
Interaction	SNRPE interactions	RBM5 EWSR1 TAF15 EYA4 FUS	6.34e-04	305	46	5	int:SNRPE
Interaction	FBXW11 interactions	RBM5 FUS ILF3 NF1 RBM10 BAG4	6.84e-04	473	46	6	int:FBXW11
Interaction	SRPK1 interactions	EWSR1 NOL4L TAF15 FUS ILF3 DDX5	7.15e-04	477	46	6	int:SRPK1
Interaction	ARIH2 interactions	EWSR1 TAF15 FUS ILF3 BAG4	7.22e-04	314	46	5	int:ARIH2
GeneFamily	Zinc fingers RANBP2-type \|RNA binding motif containing	RBM5 EWSR1 TAF15 FUS RBM10	2.94e-10	21	33	5	89
GeneFamily	RNA binding motif containing	RBM5 EWSR1 TAF15 FUS RBM10	3.93e-05	213	33	5	725
GeneFamily	AT-rich interaction domain containing	ARID1B ARID1A	3.34e-04	15	33	2	418
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	RBM5 RBM10	7.29e-04	22	33	2	579
GeneFamily	Zinc fingers C2H2-type\|Lysine methyltransferases\|PR/SET domain family	SETD2 NSD3	1.75e-03	34	33	2	487
Coexpression	ZHAN_MULTIPLE_MYELOMA_UP	EWSR1 ILF3 PTPRK RBM10	4.88e-06	64	46	4	M3958
Coexpression	GSE12507_PDC_CELL_LINE_VS_IMMATUE_T_CELL_LINE_UP	TCF4 TSHZ1 TAF15 FUS NF1	7.17e-06	153	46	5	M438
Coexpression	GRESHOCK_CANCER_COPY_NUMBER_UP	EWSR1 TAF15 FCRL4 FUS NF1 NSD3	2.07e-05	323	46	6	M9150
Coexpression	BUSSLINGER_GASTRIC_X_CELLS	RFX6 CHD7 IRX2 PCLO DDX5	2.10e-05	191	46	5	M40019
Coexpression	GSE14308_TH1_VS_TH17_DN	RBM5 SETD2 ARID1A HLA-DQA1 DDX5	2.62e-05	200	46	5	M3374
Coexpression	BENPORATH_SOX2_TARGETS	TAF15 ARID1B FUS ILF3 TCF20 IRX2 DDX5 NSD3	3.71e-05	734	46	8	M3835
Coexpression	DOUGLAS_BMI1_TARGETS_UP	TMEFF1 ARID1B DLX5 ILF3 TEX15 PCSK6 BAG4	5.26e-05	563	46	7	M15103
Coexpression	JOHNSTONE_PARVB_TARGETS_3_DN	TMEFF1 SETD2 TSHZ1 EWSR1 KLHDC10 ARID1A NSD3 BAG4	1.28e-04	877	46	8	M2241
Coexpression	BENPORATH_OCT4_TARGETS	TCF4 ARID1B FUS TCF20 IRX2	1.51e-04	290	46	5	M17183
Coexpression	MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_12	TAF15 NF1	1.64e-04	11	46	2	M16845
Coexpression	FAN_EMBRYONIC_CTX_BIG_GROUPS_INHIBITORY	TCF4 DLX5	1.97e-04	12	46	2	M39023
Coexpression	BENPORATH_NOS_TARGETS	ARID1B FUS TCF20 IRX2	2.74e-04	179	46	4	M14573
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	SETD2 CHD7 NF1 ARID1A	2.80e-04	180	46	4	M8239
Coexpression	BENPORATH_NANOG_TARGETS	SECISBP2 ARID1B FUS ILF3 TCF20 IRX2 DDX5 NSD3	2.89e-04	988	46	8	M6616
Coexpression	GSE41867_LCMV_ARMSTRONG_VS_CLONE13_DAY15_EFFECTOR_CD8_TCELL_DN	TSHZ1 DRD5 TMC5 SCML1	3.17e-04	186	46	4	M9510
Coexpression	LIAO_METASTASIS	ROBO1 CHD7 FUS FIGN HLA-DQA1 RBM10	3.46e-04	540	46	6	M13809
Coexpression	TABULA_MURIS_SENIS_MESENTERIC_ADIPOSE_TISSUE_ENDOTHELIAL_CELL_AGEING	FUS HLA-DQA1 NSD3	3.64e-04	79	46	3	MM3780
Coexpression	SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP	TMEFF1 COL3A1 ROBO1 TCF4 HLA-DQA1	3.70e-04	352	46	5	M17471
Coexpression	SENESE_HDAC3_TARGETS_DN	COL3A1 TCF4 NOL4L FIGN PCLO NSD3	3.74e-04	548	46	6	M16859
Coexpression	GSE13738_RESTING_VS_TCR_ACTIVATED_CD4_TCELL_UP	SECISBP2 TSHZ1 NOL4L SCML1	3.80e-04	195	46	4	M3319
Coexpression	GSE10325_CD4_TCELL_VS_BCELL_DN	TCF4 PTPRK HLA-DQA1 SYNGR2	3.80e-04	195	46	4	M3077
Coexpression	GSE37301_LYMPHOID_PRIMED_MPP_VS_PRO_BCELL_DN	TMEFF1 SECISBP2 ROBO1 EYA4	3.87e-04	196	46	4	M8856
Coexpression	GSE19941_LPS_VS_LPS_AND_IL10_STIM_IL10_KO_NFKBP50_KO_MACROPHAGE_UP	TMEFF1 CP TCF4 DDX5	4.10e-04	199	46	4	M8119
Coexpression	GSE10273_HIGH_VS_LOW_IL7_TREATED_IRF4_8_NULL_PRE_BCELL_DN	SEC16B CHD7 HLA-DQA1 NSD3	4.10e-04	199	46	4	M316
Coexpression	GSE1460_DP_THYMOCYTE_VS_NAIVE_CD4_TCELL_CORD_BLOOD_DN	DLX5 HLA-DQA1 SCML1 PCLO	4.10e-04	199	46	4	M3460
Coexpression	GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_UP	CHD7 TCF20 ARID1A DDX5	4.10e-04	199	46	4	M9255
Coexpression	GSE12366_PLASMA_CELL_VS_NAIVE_BCELL_DN	SETD2 ARID1A SCML1 SYNGR2	4.10e-04	199	46	4	M3175
Coexpression	GSE17301_IFNA2_VS_IFNA2_AND_ACD3_ACD28_STIM_CD8_TCELL_UP	ROBO1 ZCCHC2 TCF20 BAG4	4.18e-04	200	46	4	M8042
Coexpression	GSE4748_CTRL_VS_LPS_STIM_DC_3H_UP	COL3A1 RBM5 FUS RBM10	4.18e-04	200	46	4	M6480
Coexpression	GSE42021_TREG_PLN_VS_CD24HI_TREG_THYMUS_UP	ILF3 NF1 PCSK6 DDX5	4.18e-04	200	46	4	M9610
Coexpression	GSE39152_CD103_NEG_VS_POS_MEMORY_CD8_TCELL_DN	TCF20 HLA-DQA1 PCLO SYNGR2	4.18e-04	200	46	4	M9074
ToppCell	remission-B_intermediate\|World / disease stage, cell group and cell class	TCF4 CHD7 FCRL4 PTPRK HLA-DQA1 SYNGR2	5.51e-08	194	47	6	78556b60c84c7bbffa1c8bf8684b3c427512da44
ToppCell	mild-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 ARID1B CHD7 FCRL4 PTPRK HLA-DQA1	6.60e-08	200	47	6	fe815824e9e4be3f3db73610e3814a7fd533da65
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Interneuron\|6m / Sample Type, Dataset, Time_group, and Cell type.	TCF4 UNC13C CHD7 DLX5 SYNPR PCLO	6.60e-08	200	47	6	274871d632bbbe03720726a59ab3ec6d5fa0da11
ToppCell	TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma-9\|TCGA-Bladder / Sample_Type by Project: Shred V9	CP PTPRK C2orf78 NSD3 BAG4	2.80e-07	132	47	5	48449e2e95804a26f204ac7ea763dee26cf794ab
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CP TCF4 DLX5 TMC5 SYNPR	5.11e-07	149	47	5	10ffd0051fb027bbebc662ca602c80d89bbf99c6
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-Immature_Interneurons\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	TSHZ1 CHD7 DLX5 SYNPR DDX5	1.16e-06	176	47	5	62870115e31170c8b42eec57c709e0fe32388b37
ToppCell	pdx\|World / Sample and Cell Type and Tumor Cluster (all cells)	ROBO1 ARID1B FUS TCF20 ARID1A	1.52e-06	186	47	5	de8e538c8767d41b8a52f5e58ba1affd4e7244c4
ToppCell	pdx-Tumor_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	ROBO1 ARID1B FUS TCF20 ARID1A	1.52e-06	186	47	5	0b88a87158a9ca8de3bf40a4ff1687150707a5f0
ToppCell	Mesenchymal-myofibroblast_cell\|World / Lineage, Cell type, age group and donor	COL3A1 ROBO1 TCF4 UNC13C EYA4	1.65e-06	189	47	5	44e37f88137bb249933eb615235b2cf2ae7f3925
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	TCF4 ARID1B CHD7 DLX5 SYNPR	1.69e-06	190	47	5	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	COL3A1 ROBO1 TCF4 PCSK6 DDX5	1.74e-06	191	47	5	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-2\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 CHD7 PTPRK HLA-DQA1 NSD3	1.78e-06	192	47	5	ef86d82e4f04f9f54e821ef496d70fc81072d773
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TCF4 FCRL4 PTPRK HLA-DQA1 SYNGR2	1.83e-06	193	47	5	437ae3b10d169bb371f7b92d57a77f43e3f8d64d
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate\|Convalescent / Location, Disease Group, Cell group, Cell class (2021.03.09)	TCF4 FCRL4 PTPRK HLA-DQA1 SYNGR2	1.83e-06	193	47	5	94b5a4a4e9faaa95cb72907a2f0497429c72e516
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TCF4 CHD7 FCRL4 PTPRK HLA-DQA1	1.87e-06	194	47	5	2b61023a602d336ed0de174e9141046173db34e6
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	COL3A1 ROBO1 TCF4 UNC13C DLX5	1.87e-06	194	47	5	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TCF4 CHD7 FCRL4 PTPRK HLA-DQA1	1.87e-06	194	47	5	f2486b19ac52a48d19f80b38a5536bee3dad745b
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	COL3A1 ROBO1 TCF4 UNC13C DLX5	1.92e-06	195	47	5	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	remission-B_intermediate\|remission / disease stage, cell group and cell class	TCF4 FCRL4 PTPRK HLA-DQA1 SYNGR2	1.92e-06	195	47	5	ee14d00eb5800fadd57c2304e9461534d8668674
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-6_mon-Neuronal-INs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	TCF4 CHD7 DLX5 SYNPR DDX5	1.97e-06	196	47	5	556e18eae05bf19259fe02848bcc9120aa2a9d29
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-Immature_Interneurons\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	TCF4 CHD7 DLX5 SYNPR DDX5	2.07e-06	198	47	5	5798640425cabf4ac517b7f96a9dfd32f6e5e7c5
ToppCell	severe-B_intermediate\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 CHD7 FCRL4 HLA-DQA1 SYNGR2	2.12e-06	199	47	5	17283d75a2a900369f63ed02996e7ede97f46140
ToppCell	severe-B_intermediate\|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 FCRL4 PTPRK HLA-DQA1 SYNGR2	2.18e-06	200	47	5	6d0ac3d00400dd5657ee266f7b885381bf790ce1
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	SETD2 ARID1B FUS ZCCHC2 DDX5	2.18e-06	200	47	5	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	mild-B_intermediate\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 CHD7 FCRL4 PTPRK HLA-DQA1	2.18e-06	200	47	5	8e3132a1fe3708f725c5c4077878fb87bbea3678
ToppCell	mild-B_naive\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	TCF4 ARID1B CHD7 PTPRK HLA-DQA1	2.18e-06	200	47	5	222789b897e2a683bbfd1d00b6fd8705015d90df
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	UNC13C DLX5 EYA4 SYNPR	4.98e-06	107	47	4	fc07dd90f280191bd643398eac5c8273651d0925
ToppCell	Thalamus\|World / BrainAtlas - Mouse McCarroll V32	UNC13C TEX15 FIGN IRX2	6.87e-06	116	47	4	5ddfb2dd5459ff6d7ae38163a38eae64fda283b7
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Hpse_Sema3c\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	UNC13C RFX6 DLX5 SYNPR	8.39e-06	122	47	4	eae9d94f8510ac0f434942451d55c7260977b178
ToppCell	Epithelial-Epithelial-D_(Clara-Club_cells)\|Epithelial / shred on cell class and cell subclass (v4)	CP EYA4 FIGN PCSK6	8.66e-06	123	47	4	caa1576f1b5eb592d522be61c090ac444e277ac5
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac2_Myh4\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	UNC13C DLX5 EYA4 SYNPR	1.05e-05	129	47	4	f83187c0bb06528127b8d2d56674ab1946846951
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	UNC13C EYA4 TMC5 SYNPR	1.48e-05	141	47	4	091b5b72811db5fca2314f4a79d467566920e257
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	UNC13C DLX5 SYNPR PCSK6	1.75e-05	147	47	4	50e86860a94be103092c40e39a172eac92372f0d
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	ROBO1 TEX15 HLA-DQA1 SCML1	2.10e-05	154	47	4	5967a0a33456d5930fc492a700ebb015ac050abb
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW19\|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type.	TMEFF1 COL3A1 FUS DDX5	2.15e-05	155	47	4	9d53caee196b5c2bbc90c4f54f693b64d4086065
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CP TCF4 TMC5 SYNPR	2.15e-05	155	47	4	99e749f7075e2c64e9a0bf91009f95b6969197c8
ToppCell	Posterior_cortex-Neuronal-Inhibitory-iN2(Gad1Gad2)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	TCF4 DLX5 TMC5 SYNPR	2.15e-05	155	47	4	105d59d8a1bb8cb37eef2c1767d737b2108ac7c5
ToppCell	PBMC-Severe-Myeloid-cDC-cDC-cDC_11\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	ROBO1 TEX15 HLA-DQA1 SCML1	2.15e-05	155	47	4	fab281db4c275d51240b122be78713c839ba5a95
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Rspo4_Rxfp1_Chat\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CP TCF4 DLX5 SYNPR	2.15e-05	155	47	4	3b8def9e8f66511736ea37f259511f7c8b7743af
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chrna2_Glra3\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	UNC13C DLX5 SYNPR PCSK6	2.44e-05	160	47	4	0bfdaf979e6f128cba2928ce16bca4d3deff8ac9
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO1 TCF4 TMC5 FIGN	2.50e-05	161	47	4	1b805f77790aeb8a71b08bfac2fe2eed7343258f
ToppCell	normal_Lymph_Node-B_lymphocytes-Undetermined\|normal_Lymph_Node / Location, Cell class and cell subclass	TCF4 CHD7 HLA-DQA1 NSD3	2.56e-05	162	47	4	91ac35ae7fde411cd6a44e715a33dac62419cab8
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-ABC_aged-B_memory\|bone_marrow / Manually curated celltypes from each tissue	COL3A1 TCF4 FCRL4 HLA-DQA1	2.62e-05	163	47	4	30f5c93c4e170304d701b5231f0d545f404066f7
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_1\|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type.	ROBO1 UNC13C DLX5 PCLO	2.75e-05	165	47	4	9795ce31689bc63f5a2d68725ef00b23a90c3846
ToppCell	PBMC-Severe-Lymphocyte-B-B_cell-B_naive-B_naive-1\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 PTPRK HLA-DQA1 NSD3	2.75e-05	165	47	4	fead3f2032f8fa5f7f0159a4434989b3d65debbb
ToppCell	droplet-Heart-nan-24m-Hematologic-red_blood_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEC16B NOL4L ZCCHC2	2.85e-05	56	47	3	55337ff90621e1fea4d747ae2559c0fa61b38dce
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Pygm_C1ql1\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CP TCF4 DLX5 SYNPR	2.95e-05	168	47	4	f3879a8e11eaf866f37c52e67021be43f0b8784a
ToppCell	frontal_cortex-Neuronal-GABAergic_neuron-Vip\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CP TCF4 DLX5 SYNPR	3.16e-05	171	47	4	5efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCell	ICU-SEP-Lymphocyte-B-B_intermediate\|ICU-SEP / Disease, Lineage and Cell Type	TCF4 FCRL4 HLA-DQA1 PCLO	3.16e-05	171	47	4	2e44bf6f3d90193e7cadcac48bb852bd632a81bc
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO1 TCF4 TMC5 FIGN	3.24e-05	172	47	4	08a3fe536b1b064c5ee7779bc2b1115a5963a26b
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ROBO1 TCF4 TMC5 FIGN	3.24e-05	172	47	4	553701349444eb366df3c11f54bb093434f153c6
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_naive-B_naive-4\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 CHD7 PTPRK HLA-DQA1	3.24e-05	172	47	4	62ed3b70fa1f6c84ea80ff00f60d2562be292e9d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CP TCF4 DLX5 SYNPR	3.24e-05	172	47	4	7e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL3A1 ROBO1 UNC13C EYA4	3.31e-05	173	47	4	1f16d47f5548e257e4b17f8070c5619780a9c5fd
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	CP TCF4 DLX5 SYNPR	3.54e-05	176	47	4	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	PBMC-Convalescent-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 FCRL4 PTPRK HLA-DQA1	3.70e-05	178	47	4	be1d991c5a0a5be22f14f57d34ee1330f1a12963
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27\|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 PTPRK HLA-DQA1 SCML1	3.78e-05	179	47	4	a28a1de500a74c6dcc43481abf9ec0f7e7a300a9
ToppCell	COVID-19_Moderate-B_intermediate\|World / disease group, cell group and cell class	TCF4 FCRL4 PTPRK HLA-DQA1	3.86e-05	180	47	4	bd81b87a6dc81e5ab4a6c948eb0c80f14401a6a7
ToppCell	renal_papilla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	TCF4 UNC13C EYA4 TMC5	3.86e-05	180	47	4	49829e833fe6d2431cfd2e8f378c2aaa3b2b46a4
ToppCell	Children_(3_yrs)-Mesenchymal-myofibroblast_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	COL3A1 ROBO1 UNC13C EYA4	3.86e-05	180	47	4	01f2e5d96016823482f89ba503d007d4bd88eeac
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CP DLX5 FIGN PCSK6	3.95e-05	181	47	4	b0fff0defba9aea6fba36e378b05a59986e2573a
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CP DLX5 FIGN PCSK6	3.95e-05	181	47	4	cc77ac0e223e012767222e45c5dcadc246d1aa7c
ToppCell	facs-Lung-18m-Endothelial-lymphatic_endothelial\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CP DLX5 FIGN PCSK6	3.95e-05	181	47	4	ecd52f33841f4e9d946a4edad0d58da9b0cc5ffa
ToppCell	normal-na-Lymphocytic_B-B_mem-male\|normal / PBMC cell types (v2) per disease, treatment status, and sex	TCF4 CHD7 EYA4 HLA-DQA1	4.03e-05	182	47	4	ee36ea6cb9a5a08aeb83f2b7a249255f0b1a9870
ToppCell	remission-B_naive\|World / disease stage, cell group and cell class	TCF4 CHD7 PTPRK HLA-DQA1	4.03e-05	182	47	4	cc1dfd2de35aee1a26f7efd78e108b60a3556ec5
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO1 UNC13C FIGN PCLO	4.21e-05	184	47	4	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO1 UNC13C FIGN PCLO	4.21e-05	184	47	4	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ROBO1 UNC13C FIGN PCLO	4.21e-05	184	47	4	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C CHD7 SYNPR PCLO	4.39e-05	186	47	4	d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCell	COPD-Epithelial-Goblet\|World / Disease state, Lineage and Cell class	CP EYA4 TMC5 PTPRK	4.39e-05	186	47	4	d75fe7640a4b2c450c9759a1b3c3ef2a087f0092
ToppCell	BL-critical-LOC-Lymphoid-B_cell\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	TCF4 FCRL4 HLA-DQA1 SYNGR2	4.39e-05	186	47	4	27d4c38b180e4ce2bf3e7c4ad3db3a2ffca05ca8
ToppCell	primary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2\|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ROBO1 TCF4 FIGN SYNPR	4.48e-05	187	47	4	ae2ee6f8e5c37cb88a67f3e742cf86e57657bfaf
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	UNC13C DLX5 EYA4 FIGN	4.48e-05	187	47	4	f1d0fc625e0e7881b3f290742fd7148d995eb71e
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	UNC13C DLX5 EYA4 FIGN	4.48e-05	187	47	4	02e7246ef5ad41773d14426254e139b156d45c1d
ToppCell	10x_3'_v3-bone_marrow_(10x_3'_v3)-lymphocytic-B_lymphocytic-memory_B_cell\|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TCF4 PTPRK HLA-DQA1 SYNGR2	4.48e-05	187	47	4	b5cb8760fa667c237902d50a78dea4cb1babd607
ToppCell	severe_influenza-B_intermediate\|severe_influenza / disease group, cell group and cell class (v2)	TCF4 CHD7 FCRL4 HLA-DQA1	4.48e-05	187	47	4	d6db8595aa72fdabc4a056ba6ce09876868a66d5
ToppCell	10x3'2.3-week_12-13-Mesenchymal_adipo-stroma-adipo-CAR\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	UNC13C DLX5 EYA4 FIGN	4.48e-05	187	47	4	08c73d125e0638c9e9878165bba2442c266c8a48
ToppCell	facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	UNC13C CHD7 IRX2 PCLO	4.48e-05	187	47	4	1b2fdbfb1ce3f19795dfc4b1da5a94f4b057ec41
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CHD7 FIGN C2orf78 SYNPR	4.48e-05	187	47	4	eb011a3d8a3025cebb0fba36d403be906305372c
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SEC16B RFX6 PCLO DDX5	4.58e-05	188	47	4	a91443aa8fa8fa87f7501c59219daa0305bd0bbf
ToppCell	ILEUM-non-inflamed-(2)_Memory_B_cells\|non-inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	TCF4 FCRL4 HLA-DQA1 SYNGR2	4.67e-05	189	47	4	8d9b8a952db78646f137526f3175ba502f1d3692
ToppCell	wk_15-18-Mesenchymal-Fibroblast-Airway_fibro\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	COL3A1 ROBO1 TCF4 EYA4	4.67e-05	189	47	4	4f9608b84d135268a17455661870c46ae8554a24
ToppCell	10x5'-blood-Lymphocytic_B\|blood / Manually curated celltypes from each tissue	TCF4 PTPRK HLA-DQA1 SYNGR2	4.67e-05	189	47	4	9837dca502c9a7f42efb0bc74f3e88e7461e7dc8
ToppCell	10x5'-blood-Lymphocytic_B-Memory_B_cells\|blood / Manually curated celltypes from each tissue	TCF4 PTPRK HLA-DQA1 SYNGR2	4.67e-05	189	47	4	8aa65ffc396ccc5e86a6d38b99a2d51c34c9b6d2
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 PTPRK HLA-DQA1 SYNGR2	4.77e-05	190	47	4	60bb6aaea9691d07295f61c14d1650f5041a0f9c
ToppCell	COVID_vent-Lymphocytic-B_cell\|COVID_vent / Disease condition, Lineage, Cell class and subclass	TCF4 CHD7 PTPRK HLA-DQA1	4.77e-05	190	47	4	40b5e9e8f8fd8d84cb5b43e67b49267082348e9f
ToppCell	COVID_vent-Lymphocytic-B_cell-\|COVID_vent / Disease condition, Lineage, Cell class and subclass	TCF4 CHD7 PTPRK HLA-DQA1	4.77e-05	190	47	4	a37a32dc1b931562a6660074e19d5598efc65284
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	COL3A1 ROBO1 TCF4 DDX5	4.77e-05	190	47	4	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory-B_memory-0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 CHD7 HLA-DQA1 SYNGR2	4.77e-05	190	47	4	95b9334573eefb132daaa9371377ad60232006ae
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	UNC13C NOL4L EYA4 TMC5	4.87e-05	191	47	4	3e828cffa24ded19f591a7ed6c1fe88ad57fdcac
ToppCell	Control-Lymphoid_B\|Control / Disease group, lineage and cell class	TCF4 CHD7 PTPRK HLA-DQA1	4.87e-05	191	47	4	0a760cd3a48c487ec899adb882fddea8914cfe0c
ToppCell	COPD-Epithelial-Club\|COPD / Disease state, Lineage and Cell class	CP TMC5 PTPRK IRX2	4.87e-05	191	47	4	c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCell	Fetal_brain-fetalBrain_Zhong_nature-GW19\|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type.	COL3A1 FUS HLA-DQA1 DDX5	4.87e-05	191	47	4	b5328733da3d3d77c4f6fc5e2ba2035f8898f172
ToppCell	Neuron-Postmitotic-Inhibitory_Neuron\|World / Primary Cells by Cluster	TCF4 CHD7 DLX5 SYNPR	4.87e-05	191	47	4	4dd9c8117c4499ed9bde127baf2598603a82080d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_memory\|lymph-node_spleen / Manually curated celltypes from each tissue	TCF4 FCRL4 HLA-DQA1 SYNGR2	4.87e-05	191	47	4	c3ca8077da8594fb493e47ac4dfbbd20bfc14b37
ToppCell	5'-Adult-SmallIntestine-Hematopoietic-B_cells-Memory_B\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TCF4 FCRL4 HLA-DQA1 SYNGR2	4.87e-05	191	47	4	ce0217d375af6b19252a45340b72241ea7b204d4
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_memory\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 CHD7 HLA-DQA1 SYNGR2	4.87e-05	191	47	4	22134a2c1a92208bc1629a620ce73a56502613c2
ToppCell	PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-0\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TCF4 CHD7 PTPRK HLA-DQA1	4.87e-05	191	47	4	5a9a592875fbd0b1429b48db29a760fdc9c2c856
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TCF4 ARID1B CHD7 HLA-DQA1	4.97e-05	192	47	4	446c61c0d6ba89c619efe87ee495951299953981
ToppCell	droplet-Kidney-nan-18m-Epithelial-Epcam____thick_ascending_tube_S_epithelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	IRX2 PCLO PCSK6 BAG4	4.97e-05	192	47	4	e19e3e8edcc08e4a67873bfb6e46489ca6c8756a
Drug	A-skin	EWSR1 TAF15 FUS	3.67e-05	32	46	3	CID000208772
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A	RBM5 TCF4 TAF15 EYA4 NSD3	3.89e-05	189	46	5	4271_DN
Drug	fusarochromenone	CP FUS	3.98e-05	5	46	2	CID000107777
Drug	Estradiol-17 beta [50-28-2]; Down 200; 14.6uM; PC3; HT_HG-U133A	RBM5 TCF4 EYA4 ILF3 NSD3	3.99e-05	190	46	5	6718_DN
Drug	PNU-0293363 [326823-19-2]; Up 200; 10uM; MCF7; HT_HG-U133A	RBM5 TAF15 FUS ILF3 SCML1	4.19e-05	192	46	5	6573_UP
Drug	Amethopterin (R,S) [59-05-2]; Down 200; 8.8uM; HL60; HG-U133A	SETD2 TAF15 NF1 ARID1A RBM10	4.19e-05	192	46	5	1599_DN
Drug	Capsaicin [404-86-4]; Down 200; 13uM; PC3; HT_HG-U133A	RBM5 TCF4 SETD2 TAF15 FUS	4.40e-05	194	46	5	4612_DN
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	RBM5 SETD2 NF1 PCLO NSD3	4.40e-05	194	46	5	4727_DN
Drug	EMCs	EWSR1 TAF15 FUS	4.42e-05	34	46	3	CID005091655
Drug	Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; PC3; HT_HG-U133A	TAF15 ILF3 TEX15 NF1 NSD3	4.51e-05	195	46	5	4508_DN
Drug	Sulfadoxine [2447-57-6]; Down 200; 12.8uM; PC3; HT_HG-U133A	RBM5 TAF15 FUS TMC5 NSD3	4.85e-05	198	46	5	5852_DN
Drug	Carbetapentane citrate [23142-01-0]; Down 200; 7.6uM; PC3; HT_HG-U133A	CHD7 EYA4 ILF3 NF1 KLHDC10	4.97e-05	199	46	5	4649_DN
Drug	Mephenesin [59-47-2]; Up 200; 22uM; PC3; HT_HG-U133A	RBM5 EYA4 NF1 ARID1A NSD3	4.97e-05	199	46	5	7374_UP
Drug	Alprenolol hydrochloride [13707-88-5]; Down 200; 14uM; MCF7; HT_HG-U133A	SETD2 TAF15 NF1 TMC5 BAG4	5.09e-05	200	46	5	6789_DN
Disease	amyotrophic lateral sclerosis type 6 (implicated_via_orthology)	EWSR1 TAF15 FUS	3.31e-09	3	45	3	DOID:0060198 (implicated_via_orthology)
Disease	frontotemporal dementia (implicated_via_orthology)	EWSR1 TAF15 FUS	7.22e-07	12	45	3	DOID:9255 (implicated_via_orthology)
Disease	amyotrophic lateral sclerosis (implicated_via_orthology)	EWSR1 TAF15 FUS	1.31e-05	30	45	3	DOID:332 (implicated_via_orthology)
Disease	Fc receptor-like protein 4 measurement	FCRL4 PCSK6	1.36e-05	4	45	2	EFO_0801599
Disease	Extraskeletal Myxoid Chondrosarcoma	EWSR1 TAF15	2.27e-05	5	45	2	C1275278
Disease	MENTAL RETARDATION, AUTOSOMAL DOMINANT 12	ARID1B ARID1A	2.27e-05	5	45	2	C3281201
Disease	diet measurement	ROBO1 SEC16B UNC13C ARID1B TEX15 NF1 ZCCHC2 TCF20 HLA-DQA1	2.45e-05	1049	45	9	EFO_0008111
Disease	Prostatic Neoplasms	ROBO1 SETD2 RFX6 EWSR1 CHD7 ARID1A PTPRK	3.81e-05	616	45	7	C0033578
Disease	Malignant neoplasm of prostate	ROBO1 SETD2 RFX6 EWSR1 CHD7 ARID1A PTPRK	3.81e-05	616	45	7	C0376358
Disease	cognitive function measurement	SEC16B TCF4 RFX6 NOL4L ARID1B CHD7 ZCCHC2 TCF20 FIGN PCSK6	4.78e-05	1434	45	10	EFO_0008354
Disease	Embryonal Rhabdomyosarcoma	SETD2 ARID1A	6.33e-05	8	45	2	C0206656
Disease	emphysema imaging measurement	SEC16B UNC13C PTPRK HLA-DQA1	7.32e-05	146	45	4	EFO_0007626
Disease	Amyotrophic Lateral Sclerosis	EWSR1 TAF15 FUS	9.64e-05	58	45	3	C0002736
Disease	neuroblastoma (is_implicated_in)	ARID1B ARID1A	1.02e-04	10	45	2	DOID:769 (is_implicated_in)
Disease	arterial stiffness measurement	TCF20 PTPRK HLA-DQA1	1.29e-04	64	45	3	EFO_0004517
Disease	hearing loss	EYA4 PTPRK HLA-DQA1	1.48e-04	67	45	3	EFO_0004238
Disease	urinary albumin to creatinine ratio	TCF4 UNC13C CHD7 HLA-DQA1	1.61e-04	179	45	4	EFO_0007778
Disease	mitochondrial heteroplasmy measurement	UNC13C HLA-DQA1 DDX5	1.62e-04	69	45	3	EFO_0600008
Disease	Coffin-Siris syndrome	ARID1B ARID1A	1.76e-04	13	45	2	C0265338
Disease	nodular sclerosis Hodgkin lymphoma	PTPRK HLA-DQA1	2.05e-04	14	45	2	EFO_0004708
Disease	alcohol use disorder (implicated_via_orthology)	UNC13C ARID1B DRD5 ARID1A	2.23e-04	195	45	4	DOID:1574 (implicated_via_orthology)
Disease	Replication Error Phenotype	SETD2 ARID1A	2.36e-04	15	45	2	C1721098
Disease	Microsatellite Instability	SETD2 ARID1A	2.36e-04	15	45	2	C0920269
Disease	Dementia	CP FUS	3.05e-04	17	45	2	C0497327
Disease	alcohol use disorder measurement	TCF4 NOL4L NF1 TCF20	3.17e-04	214	45	4	EFO_0009458
Disease	Tourette syndrome, schizophrenia	TCF20 NSD3	3.43e-04	18	45	2	EFO_0004895, MONDO_0005090
Disease	chronotype measurement	RBM5 TCF4 TSHZ1 NOL4L ILF3 ZCCHC2 TCF20	3.51e-04	882	45	7	EFO_0008328
Disease	Neurodevelopmental Disorders	TCF4 SETD2 ARID1B	3.91e-04	93	45	3	C1535926
Disease	serum gamma-glutamyl transferase measurement	ROBO1 SEC16B SETD2 TSHZ1 NF1 ARID1A HLA-DQA1	4.34e-04	914	45	7	EFO_0004532
Disease	Autoimmune Hepatitis	HLA-DQA1 SYNPR	4.69e-04	21	45	2	EFO_0005676
Disease	vital capacity	TMEFF1 CHD7 EYA4 MTMR11 TCF20 HLA-DQA1 PCLO DDX5	5.02e-04	1236	45	8	EFO_0004312
Disease	Henoch-Schoenlein purpura	FIGN HLA-DQA1	5.15e-04	22	45	2	EFO_1000965
Disease	cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement	TCF20 ARID1A HLA-DQA1	5.27e-04	103	45	3	EFO_0008595, EFO_0020944
Disease	melanoma	CP RFX6 NF1 PTPRK	5.54e-04	248	45	4	C0025202
Disease	granulocyte percentage of myeloid white cells	SETD2 CHD7 ARID1A HLA-DQA1	7.40e-04	268	45	4	EFO_0007997
Disease	triacylglycerol 50:1 measurement	EWSR1 HLA-DQA1	7.79e-04	27	45	2	EFO_0010408
Disease	unipolar depression, irritable bowel syndrome	TCF4 PCLO	8.38e-04	28	45	2	EFO_0000555, EFO_0003761
Disease	longevity, healthspan, parental longevity	NOL4L HLA-DQA1	8.99e-04	29	45	2	EFO_0004300, EFO_0007796, EFO_0009762
Disease	risk-taking behaviour	TCF4 ARID1B NF1 TCF20 FIGN HLA-DQA1	1.02e-03	764	45	6	EFO_0008579
Disease	self rated health	TCF4 HLA-DQA1	1.03e-03	31	45	2	EFO_0004778
Disease	Malignant neoplasm of breast	ROBO1 SETD2 ARID1B FUS NF1 KLHDC10 ARID1A	1.12e-03	1074	45	7	C0006142
Disease	attention deficit hyperactivity disorder, substance abuse, antisocial behaviour measurement	TCF4 ARID1B CHD7 TCF20 FIGN PTPRK	1.30e-03	801	45	6	EFO_0003888, EFO_0007052, MONDO_0002491
Disease	cortical thickness	ROBO1 TCF4 NOL4L ARID1B CHD7 DLX5 EYA4	1.38e-03	1113	45	7	EFO_0004840

Protein segments in the cluster

Peptide	Gene	Start	Entry
SYNQGGYNQDSYGSS	SYNPR	221	Q8TBG9
QSLNSYTNGAYGPTY	BAG4	126	O95429
QGYSAYTAQPTQGYA	EWSR1	16	Q01844
QTTQAYGQQSYGTYG	EWSR1	31	Q01844
YGQQSYGTYGQPTDV	EWSR1	36	Q01844
SYAAQSAYGTQPAYP	EWSR1	111	Q01844
SSYSQQNTYGQPSSY	EWSR1	206	Q01844
YGQQSSYGQQPPTSY	EWSR1	226	Q01844
QIGSQVYYYNQGTLG	C2orf78	206	A6NCI8
GYYCTADNSYGPVQS	FCRL4	356	Q96PJ5
GVSGYCQQGQQPYYS	ARID1B	671	Q8NFD5
SPTINNSGQYSRYPY	CHD7	301	Q9P2D1
NSGQYSRYPYSNLNQ	CHD7	306	Q9P2D1
NPYQYQYHGVNGSAG	DLX5	71	P56178
VNLYQSYGPSGQYTH	HLA-DQA1	36	P01909
QGYGQASQSYSGYGQ	TAF15	26	Q92804
YGQNYSGYSSYGQSQ	TAF15	46	Q92804
SGYSQSYGGYENQKQ	TAF15	61	Q92804
SYGGYENQKQSSYSQ	TAF15	66	Q92804
SYYQQDEGYGNSQGT	RBM10	436	P98175
NSPNGYYGSNINYPE	RFX6	796	Q8HWS3
SNGTAYPGQFALYQQ	DRD5	6	P21918
PSPQQDVYNQYGNAY	ARID1A	1421	O14497
DVYNQYGNAYPATAT	ARID1A	1426	O14497
NEGTYYSPNYNPQSR	CP	486	P00450
SSYGNYSYGQQRSTQ	FIGN	331	Q5HY92
NTYTGNPTYAQGFTG	IGHV7-81	71	A0A0B4J1V7
SGQLNSYTQVYTPGY	MTMR11	486	A4FU01
YTQQATQSYGAYPTQ	FUS	6	P35637
QPYGQQSYSGYSQST	FUS	31	P35637
SSQSSYGQQSSYPGY	FUS	86	P35637
PTKPGSQYYQYSSNN	TCF4	141	P15884
GNPTGTYQNGYDSTQ	DDX5	561	P17844
TYQNGYDSTQQYGSN	DDX5	566	P17844
YQYNYDPSGTASPQT	PCLO	3316	Q9Y6V0
APNYDSYASYDVNGN	PCSK6	216	P29122
NTNLYVFGGYNPDYD	KLHDC10	101	Q6PID8
SQDPVYANGGLNYSY	NOL4L	326	Q96MY1
LQPGQDGYAQYAQYS	RBM5	361	P52756
SPFYGNYTNYGNLNA	IRX2	386	Q9BZI1
SQQDYPSYTAFGQNQ	EYA4	266	O95677
QGSYSYSNSYNSPGG	ILF3	781	Q12906
YQGKQGGYSQSNYNS	ILF3	846	Q12906
TGPQNYSPQYDSYDV	COL3A1	146	P02461
PSSDYINANYIDGYQ	PTPRK	936	Q15262
NCQPYYASDGATYGS	SCML1	191	Q9UN30
QNVYSVPGSQYLYNQ	SECISBP2	101	Q96T21
CGTNGNLQLNSYYYP	ZCCHC2	1021	Q9C0B9
GQYDSYQGANSNELY	UNC13C	736	Q8NB66
PQYQTSYLQSFGFNG	NF1	2696	P21359
IPYNQSYDQNTGGSY	ROBO1	1136	Q9Y6N7
YASYPGASVDNYQQP	nan	191	A8MWL6
AYASYPGASVDNYQQ	SYNGR2	191	O43760
AQAYGTQSNYSYQPQ	TCF20	281	Q9UGU0
SIQNNYGAGVYYNSL	TAMM41	86	Q96BW9
ETQTKYQSYNQYPNG	NSD3	81	Q9BZ95
YQSYNQYPNGSANGF	NSD3	86	Q9BZ95
YSPAQSQATIYYQGQ	SETD2	2286	Q9BYW2
PGYENSYQSYQSPTM	SEC16B	101	Q96JE7
YPDYSGSQNRTQGYL	TMC5	16	Q6UXY8
NYIPVCGSNGDTYQN	TMEFF1	106	Q8IYR6
SQYFTYFAGEPQANG	TEX15	2711	Q9BXT5
TPNNRYGYQNGASYT	TSHZ1	391	Q6ZSZ6